These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6315215)

  • 1. Isolation and partial purification of a new class of transforming growth factors from an avian sarcoma virus-transformed rat cell line.
    Hirai R; Yamaoka K; Mitsui H
    Cancer Res; 1983 Dec; 43(12 Pt 1):5742-6. PubMed ID: 6315215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The purification of an acid- and heat-labile transforming growth factor from an avian sarcoma virus-transformed rat cell line.
    Yamaoka K; Hirai R; Tsugita A; Mitsui H
    J Cell Physiol; 1984 Jun; 119(3):307-14. PubMed ID: 6327732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characterization of a transforming growth factor produced in rat cells transformed by an avian sarcoma virus].
    Hirai R; Yamaoka K; Mitsui H
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):607-13. PubMed ID: 6324696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of intra- and extracellular transforming growth factors from normal and avian sarcoma virus-transformed rat cells.
    Yamaoka K; Hirai R
    Biochem Int; 1986 Nov; 13(5):863-72. PubMed ID: 3028422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F.
    Pircher R; Lawrence DA; Jullien P
    Cancer Res; 1984 Dec; 44(12 Pt 1):5538-43. PubMed ID: 6093998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of sarcoma growth inhibitor from avian sarcoma virus-transformed rat cells.
    Yamaoka K; Hirai R; Hiragun A
    Jpn J Cancer Res; 1986 Apr; 77(4):319-23. PubMed ID: 3009374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor production by chemically transformed cells.
    Moses HL; Branum EL; Proper JA; Robinson RA
    Cancer Res; 1981 Jul; 41(7):2842-8. PubMed ID: 6265069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
    Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
    Tucker RF; Volkenant ME; Branum EL; Moses HL
    Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factors released from Kirsten sarcoma virus transformed cells do not compete for epidermal growth factor membrane receptors.
    Chua CC; Geiman D; Ladda RL
    J Cell Physiol; 1983 Oct; 117(1):116-22. PubMed ID: 6311845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA; Klos DJ; Grant GA
    Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor.
    van Zoelen EJ; van Oostwaard TM; van der Saag PT; de Laat SW
    J Cell Physiol; 1985 May; 123(2):151-60. PubMed ID: 2984216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.
    Anzano MA; Roberts AB; Meyers CA; Komoriya A; Lamb LC; Smith JM; Sporn MB
    Cancer Res; 1982 Nov; 42(11):4776-8. PubMed ID: 6290046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factors in solid human malignant neoplasms.
    Nickell KA; Halper J; Moses HL
    Cancer Res; 1983 May; 43(5):1966-71. PubMed ID: 6299535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factors (TGFs): properties and possible mechanisms of action.
    Todaro GJ; De Larco JE; Fryling C; Johnson PA; Sporn MB
    J Supramol Struct Cell Biochem; 1981; 15(3):287-301. PubMed ID: 6267317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells.
    Newman MJ; Lane EA; Nugent MA; Racker E
    Cancer Res; 1986 Nov; 46(11):5842-50. PubMed ID: 3019539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cells transformed by Rous sarcoma virus release transforming growth factors.
    Krycève-Martinerie C; Lawrence DA; Crochet J; Jullien P; Vigier P
    J Cell Physiol; 1982 Dec; 113(3):365-72. PubMed ID: 6294124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factors from neoplastic and nonneoplastic tissues.
    Roberts AB; Frolik CA; Anzano MA; Sporn MB
    Fed Proc; 1983 Jun; 42(9):2621-6. PubMed ID: 6303865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplicity of transforming growth factors in human malignant effusions.
    Seo MK; Lynch KE; Podolsky DK
    Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.